Daniel George, MD
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder Cancer (NCT04073160) | Daniel George, MD | 2020-06-01 |
Track Daniel George, MD automatically
Every clearance here is in the API, with alerts when new ones post.